Recent Finacing
Recent Raise
Symphogen is a Copenhagen biopharma developing recombinant antibody mixtures (mAb‑mix) for oncology, immuno‑oncology, infectious and autoimmune diseases, advancing Sym004, Sym013, and Sym015 through clinical development and partnerships.
